EUVIMEDEUVIMED entdecken
Crossref

Inferior vena cava-splenic vein shunt for the treatment of complete portal trunk occlusion and portal cavernoma in liver cirrhosis

Maoyuan Mu, Yuzhe Cao, Zixiong Chen, Xiaobo Fu, Pengyi Chen, Han Qi, Fei Gao

European Radiology · 2025

DOI: 10.1007/s00330-025-11571-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Radiology, 2025. Verfasst von Maoyuan Mu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Minimally Invasive Intervention, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Can…. Hauptthemen laut MEDLINE: Liver Cirrhosis, Vena Cava, Inferior, Hypertension, Portal, Splenic Vein. Die Arbeit nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: The transjugular intrahepatic portosystemic shunt procedure remains technically challenging in cases involving occlusion of the portal trunk. This study aimed to evaluate the feasibility, efficacy, and safety of utilizing the inferior vena cava-splenic vein shunt (IVCSS) as a new treatment option in cirrhotic patients with complete portal trunk occlusion and portal cavernoma. METHODS: The IVCSS procedure was performed on twelve patients, involving the creation of a shunt using a covered stent between the inferior vena cava and the proximal end of the splenic vein to reduce distal portal pressure. RESULTS: Technical success was achieved in all patients, with a mean procedure duration of 71.7 ± 44.2 min. The portosystemic gradient was reduced by a mean of 11.0 ± 5.6 mmHg after the procedure. After a median follow-up of 6.7 [2.8-11.4] months, clinical symptoms improved in all patients. Stent dysfunction occurred in 1 patient, the recurrence rates for variceal bleeding and ascites were 8.3% and 16.7%, respectively. One patient (8.3%) experienced a procedure-related complication of retroperitoneal hemorrhage. Three patients (25%) had an episode of hepatic encephalopathy, which improved after conservative treatment. CONCLUSION: IVCSS effectively reduced distal portal pressure, which contributed to an improvement of the patients' clinical symptoms with an acceptable procedure-related complication rate. IVCSS may serve as an alternative strategy to manage symptomatic portal hypertension for patients with complete portal trunk occlusion and portal cavernoma. KEY POINTS: Question What is an alternative treatment for cirrhotic patients with symptomatic portal hypertension caused by chronic portal vein occlusion other than TIPS? Findings Inferior vena cava-splenic vein shunt (IVCSS) is feasible for reducing distal portal pressure and effectively improving clinical symptoms. Clinical relevance For cirrhotic patients with complete portal trunk occlusion and portal cavernoma, the IVCSS approach seemed to be a promising alternative treatment for symptomatic portal hypertension.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisVena Cava, InferiorHypertension, PortalSplenic VeinPortal VeinHemangioma, CavernousPortasystemic Shunt, Transjugular IntrahepaticHumansMaleFemaleMiddle AgedTreatment OutcomeAgedAdultFeasibility StudiesStents

Stichwörter der Autor:innen

Interventional radiologyPortal hypertensionPortal veinTherapeuticsVenous thrombosis

Autor:innen und Institutionen

  • Department of Minimally Invasive Intervention, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
  • Department of Interventional Radiology, Liuzhou Municipal Liutie Central Hospital, Liuzhou, P. R. China.
  • Department of Minimally Invasive Intervention, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China. qih…
  • Department of Minimally Invasive Intervention, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China. gao…

Zitieren

APA

Mu, M., Cao, Y., Chen, Z., Fu, X., Chen, P., Qi, H., & Gao, F. (2025). Inferior vena cava-splenic vein shunt for the treatment of complete portal trunk occlusion and portal cavernoma in liver cirrhosis. European Radiology. https://doi.org/10.1007/s00330-025-11571-8

Vancouver

Mu M, Cao Y, Chen Z, Fu X, Chen P, Qi H, et al. Inferior vena cava-splenic vein shunt for the treatment of complete portal trunk occlusion and portal cavernoma in liver cirrhosis. European Radiology. 2025. doi:10.1007/s00330-025-11571-8

BibTeX
@article{Mu2025,
  author = {Mu, Maoyuan and Cao, Yuzhe and Chen, Zixiong and Fu, Xiaobo and Chen, Pengyi and Qi, Han and Gao, Fei},
  title = {Inferior vena cava-splenic vein shunt for the treatment of complete portal trunk occlusion and portal cavernoma in liver cirrhosis},
  journal = {European Radiology},
  year = {2025},
  doi = {10.1007/s00330-025-11571-8}
}
Kostenlos starten →